pSivida MD to ring NASDAQ Closing Bell
Jul 01, 2008
|
pSivida Interim results from the 3-month Human PK Medidur FA Study
Jun 27, 2008
|
Open Briefing Interview with Managing Director, Dr Paul Ashton - pSivida reincorporation in the US
Jun 20, 2008
|
pSivida Scheme of Arrangement Implemented
Jun 19, 2008
|
Jun 12, 2008
|
Jun 11, 2008
|
NASDAQ Trading To Commence
Jun 11, 2008
|
Jun 11, 2008
|
Jun 11, 2008
|
Compliance with ASX Listing Rule 3.1
Jun 11, 2008
|
Jun 10, 2008
|
Jun 06, 2008
|
Jun 06, 2008
|
Jun 06, 2008
|
Jun 04, 2008
|
pSivida to present at the Rodman & Renshaw Healthcare Conference in Monte Carlo
May 19, 2008
|
pSivida new trial to treat AMD (age related macular degeneration)
May 09, 2008
|
Shareholder Meeting - 6 June 2008
May 06, 2008
|
March Quarter, 2008 Commentary & Highlights
Apr 30, 2008
|
pSivida proposed reincorporation in the US
Apr 18, 2008
|
Displaying 501 - 520 of 530
News releases are posted on the Company's website as soon as possible after the release over the news wire. You should view the Financial Information section and most recent SEC Filings in the Investors section to receive the most current information made available by EyePoint Pharmaceuticals, Inc.